Asset Details
Do you wish to reserve the book?
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
Do you wish to request the book?
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
2020
Overview
Increasing antibiotic resistance in multidrug-resistant (MDR) Gram-negative bacteria (MDR-GNB) presents significant health problems worldwide, since the vital available and effective antibiotics, including; broad-spectrum penicillins, fluoroquinolones, aminoglycosides, and β-lactams, such as; carbapenems, monobactam, and cephalosporins; often fail to fight MDR Gram-negative pathogens as well as the absence of new antibiotics that can defeat these \"superbugs\". All of these has prompted the reconsideration of old drugs such as polymyxins that were reckoned too toxic for clinical use. Only two polymyxins, polymyxin E (colistin) and polymyxin B, are currently commercially available. Colistin has re-emerged as a last-hope treatment in the mid-1990s against MDR Gram-negative pathogens due to the development of extensively drug-resistant GNB. Unfortunately, rapid global resistance towards colistin has emerged following its resurgence. Different mechanisms of colistin resistance have been characterized, including intrinsic, mutational, and transferable mechanisms.
In this review, we intend to discuss the progress over the last two decades in understanding the alternative colistin mechanisms of action and different strategies used by bacteria to develop resistance against colistin, besides providing an update about what is previously recognized and what is novel concerning colistin resistance.
Publisher
Taylor & Francis,Taylor & Francis Ltd,Taylor & Francis Group
Subject
Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Colistin
/ Drug Resistance, Multiple, Bacterial
/ Gram-Negative Bacteria - drug effects
/ Gram-Negative Bacteria - pathogenicity
/ Gram-Negative Bacterial Infections - drug therapy
/ Gram-Negative Bacterial Infections - microbiology
/ Humans
/ MCR-1
/ Multidrug resistant organisms
/ Review
